Kono chem is located in Xi'an, Shaanxi Province, equipped with a number of engineers in Pharmaceutical, Nutrition, Bioengineering, committed themselves to create products that meet customer requirements. At present, Kono's main products cover pharmaceutical, food, cosmetics, scientific research, optoelectronic industry and other fields, marketing in more than 50 countries in the world, mainly for the Daewoong, Takeda, CIPLA and other global well-known enterprises. 

Kono's plant is located in the new district, Tongchuan city, Shaanxi province, covering an area of 312,000 square meters, with more than 35% scientific and technical personnel. The plant has two chemical fermentation workshops, one test reaction workshop and  one provincial R & D center. Since the establishment of the company, Kono strictly manages its production in accordance with the demand of ISO9000、ISO14001 and other norms and has received the recognition from customers and authoritative laboratory audits all over the world.

Persisting to the principle of“Integrity and Diligence”, Kono is rising up with its hardworking employees and efficient research and development system and will engage itself to play an active role in the development of chemical industry together with domestic and foreign colleagues!

Name: Tranexamic acid

CAS Number: 701-54-2

Molecular formula: C8H15NO2

Molecular weight: 157.21000

Density: 1.095 g/cm3

Melting point: 233ºC

Boiling point: 300.2ºC at 760 mmHg

Flash point: 135.4ºC

Tranexamic acid (TXA), also known as tranexamic acid) is a synthetic amino acid with other names such as tranexamic acid, tranexamic acid, tranexamic acid, etc. It has hemostatic and anti-inflammatory pharmacological effects. It is used as a coagulant. There are two ways to use injection and oral.

Tranexamic acid can strongly adsorb to lysine in the fibrin affinity site on plasmin and plasminogen, prevent the formation of plasmin, and inhibit the binding of plasmin, plasminogen and fibrin , Thereby strongly inhibiting the decomposition of fibrin and achieving hemostatic effect.

It can directly inhibit the activity of plasmin and reduce the effect of plasmin in activating complement, so as to prevent the occurrence of hereditary angioedema.